Immunicom
Pre-clinicalImmunicom’s Immunopheresis™ is designed to empower patients to best live their lives while receiving revolutionary cancer treatment.
Founded
2014
Focus
ImmunologyOncology
About
Immunicom’s Immunopheresis™ is designed to empower patients to best live their lives while receiving revolutionary cancer treatment.
Funding History
2Total raised: $40M
Series B$25MUndisclosedSep 15, 2020
Series A$15MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2014
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile